HOPCo Leads Digital Patient Engagement at 2025 AAHKS Annual Meeting

HOPCo's Strategy at the 2025 AAHKS Annual Meeting

The Healthcare Outcomes Performance Company (HOPCo) is at the forefront of redefining musculoskeletal (MSK) care with its innovative approaches. This week, HOPCo is prominently featured at the 2025 American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting, held from October 23 to 26 at the Gaylord Texan Resort in Grapevine, Texas. The gathering represents a major opportunity for HOPCo to showcase its cutting-edge solutions that enhance patient experiences and optimize care delivery.

Showcase of Digital Tools

During the meeting, HOPCo will spotlight its advanced digital patient engagement platforms, notably myrecovery® by HOPCo and HOPCo Vitals®. These tools are designed to facilitate better communication between healthcare providers and patients, improve adherence to care regimes, and enable real-time monitoring of recovery progress. By leveraging these digital solutions, orthopedic teams can deliver highly personalized care that significantly streamlines recovery processes. Furthermore, HOPCo is unveiling HOPCo CNS (Clinical Network Solutions), a comprehensive system aimed at optimizing the delivery of musculoskeletal care across various practices and settings, driving essential improvements in MSK outcomes through actionable insights.

Partnerships to Enhance Care Paths

Strategic collaborations form an essential part of HOPCo's strategy to broaden access to quality care. HOPCo has partnered with Smith+Nephew, a key sponsor of the event, and Caro Health, extending access to their value-based care initiatives across new markets. At the Smith+Nephew booth, HOPCo representatives will demonstrate the integration of their digital engagement solutions with broader care strategies and value-based models. This partnership is instrumental in ensuring that patients receive comprehensive and effective musculoskeletal care.

As part of the event, HOPCo has also established a dedicated booth and lounge area, providing conference attendees with a space for private discussions, interactive demonstrations, and networking while enjoying refreshments. This thoughtful addition facilitates deeper engagement with healthcare professionals and demonstrates HOPCo's commitment to fostering collaboration within the industry.

Leadership Engagement and Education

HOPCo’s executive team will be actively involved in various panels and breakout sessions throughout the event. Notably, Dr. David Jacofsky, HOPCo’s Founder and Chairman, will co-chair the Business of Total Joint Arthroplasty course, focusing on outpatient joint replacement strategies and digital tool integration. Meanwhile, Tom Harte, President of HOPCo Digital, will present insights on how technology can enhance patient engagement and improve clinical outcomes.

Dr. Michael Meneghini, currently the President of AAHKS and HOPCo’s Chief Market Development Officer, alongside Dr. Wael Barsoum, HOPCo’s President and Chief Transformation Officer, will moderate discussions related to innovation in patient care and organizational leadership. Dr. Barsoum emphasized, "At this year's AAHKS Annual Meeting, HOPCo strives to demonstrate how our technology and physician-led solutions can profoundly transform musculoskeletal care across the nation."

Research Contributions

HOPCo remains committed to advancing knowledge through research, and this year, its researchers will present significant findings in poster sessions during the meeting. Key research highlights include:

1. Activity Phenotypes Prior to Total Hip Arthroplasty: This study illustrates how preoperative activity levels significantly predict recovery trajectories, highlighting the importance of understanding patient behaviors beyond traditional metrics.
2. Sustainability in Reimbursement Models: A critical analysis reveals that stagnant reimbursements for complex revision surgeries pose serious threats to physician engagement and patient access, calling for urgent policy reforms.

These contributions underscore HOPCo's dedication to using real-world evidence to drive clinical innovation and improve patient care pathways.

About HOPCo

HOPCo stands as the global leader in musculoskeletal value-based care, dedicated to enhancing outcomes and transforming patient experiences. Engaging seamlessly with healthcare systems, payors, and physician practices, HOPCo aims to create clinically integrated models that escalate care quality while minimizing variability and costs. HOPCo Digital, their AI-driven platform, is emerging as a comprehensive solution for healthcare providers, ensuring that patient-centered care is both data-driven and efficient. With an expanding global footprint, HOPCo operates in various health markets, enabling successful implementations to foster improved healthcare delivery on a worldwide scale. For further information, visit www.hopco.com.